美国残疾成年人戒烟干预措施：系统评价方案。
Smoking cessation interventions for US adults with disabilities: protocol for a systematic review.
机构信息
Department of Psychiatry, Vermont Center on Behavior and Health, Burlington, Vermont, USA
Dana Medical Library, University of Vermont, Burlington, Vermont, USA.
出版信息
BMJ Open. 2023 Mar 22;13(3):e066700. doi: 10.1136/bmjopen-2022-066700.
INTRODUCTION
People with disabilities have a higher prevalence of cigarette smoking than people without disabilities. However, little information exists on smoking cessation interventions tailored to address the unique needs of people with disabilities. This paper describes a systematic review protocol to identify and evaluate tobacco smoking cessation interventions designed to improve outcomes for people with disabilities.
METHODS AND ANALYSIS
We will conduct a systematic review of the literature using the procedures outlined by Cochrane. We will search four electronic databases (CINAHL Plus (EBSCO), Embase (Ovid), Medline (Ovid) and PsycINFO (Ovid)) with no date restriction to identify tobacco cessation interventions tailored to meet the needs of people with disabilities. We will extract data and assess risk of bias using the RoB2 and ROBINS-I for included studies using Covidence systematic review software. Quantitative and qualitative syntheses will summarise key study characteristics and outcomes with text, tables and forest plots; a meta-analysis will be conducted, if appropriate.
ETHICS AND DISSEMINATION
Ethical approval is not required as there are no primary data associated with the study. Data will be disseminated through a peer-reviewed articles and conference presentations.
PROSPERO REGISTRATION NUMBER
CRD42022337434.
简介
残疾人的吸烟率高于非残疾人。然而，针对残疾人独特需求的戒烟干预措施的信息很少。本文描述了一个系统评价方案，以确定和评估旨在改善残疾人吸烟结局的戒烟干预措施。
方法和分析
我们将按照 Cochrane 的程序对文献进行系统评价。我们将在四个电子数据库（CINAHL Plus（EBSCO）、Embase（Ovid）、Medline（Ovid）和 PsycINFO（Ovid））中进行无日期限制的检索，以确定针对残疾人需求定制的烟草戒烟干预措施。我们将使用 Covidence 系统评价软件提取数据，并使用 RoB2 和 ROBINS-I 评估纳入研究的偏倚风险。将使用文字、表格和森林图总结关键研究特征和结果；如果合适，将进行荟萃分析。
伦理和传播
由于研究没有原始数据，因此不需要伦理批准。数据将通过同行评审的文章和会议报告进行传播。
PROSPERO 注册号：CRD42022337434。
Zotero 插件